Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease

Biochemical Pharmacology

Volumn 86, Issue 7, 2013, Pages 862-871

  Clark, Ian A ^a   Vissel, Bryce ^a,b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Alzheimer's disease; DNA hypomethylation; Insulin resistance; Parkinson's disease, Synuclein; TNF

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BEXAROTENE; CALCINEURIN; CRYOPYRIN; CYTOKINE; DNA METHYLTRANSFERASE 1; INSULIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; TACROLIMUS; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELL 2; UNCLASSIFIED DRUG; USTIKINUMAB;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ARTICLE; BRAIN RADIATION; CHEMOTHERAPY; CYTOKINE PRODUCTION; DNA METHYLATION; EPIGENETICS; HIV ASSOCIATED DEMENTIA; HUMAN; INFLUENZA A (H5N1); INSULIN RESISTANCE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 84884704633     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.07.030     Document Type: Note

References (182)

1. I. Clark, C. Atwood, R. Bowen, G. Paz-Filho, and B. Vissel Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales Pharmacological Reviews 64 2012 1004 1026
2. W.S. Griffin, L.C. Stanley, C. Ling, L. White, V. MacLeod, and L.J. Perrot Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 86 1989 7611 7615 (Pubitemid 19254506)
3. E. Tarkowski, N. Andreasen, A. Tarkowski, and K. Blennow Intrathecal inflammation precedes development of Alzheimer's disease Journal of Neurology, Neurosurgery & Psychiatry 74 2003 1200 1205
4. D. Laurin, J. David Curb, K.H. Masaki, L.R. White, and L.J. Launer Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up Neurobiology of Aging 30 2009 1724 1727
5. A. Schuitemaker, M.G. Dik, R. Veerhuis, P. Scheltens, N.S. Schoonenboom, and C.E. Hack Inflammatory markers in AD and MCI patients with different biomarker profiles Neurobiology of Aging 30 2009 1885 1889
6. I. Hardardottir, S.T. Kunitake, A.H. Moser, W.T. Doerrler, J.H. Rapp, and C. Grunfeld Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters Journal of Clinical Investigation 94 1994 1304 1309 (Pubitemid 24286476)
7. M. Thambisetty, A. Simmons, L. Velayudhan, A. Hye, J. Campbell, and Y. Zhang Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer's disease Archives of General Psychiatry 67 2010 739 748
8. J.Q. Shi, W. Shen, J. Chen, B.R. Wang, L.L. Zhong, and Y.W. Zhu Anti-TNF-alpha reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains Brain Research 1368 2011 239 247
9. R. Guerreiro, A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, and E. Majounie TREM2 variants in Alzheimer's disease New England Journal of Medicine 368 2013 117 127
10. T. Jonsson, H. Stefansson, S. Steinberg, I. Jonsdottir, P.V. Jonsson, and J. Snaedal Variant of TREM2 associated with the risk of Alzheimer's disease New England Journal of Medicine 368 2013 107 116
11. K. Takahashi, C.D. Rochford, and H. Neumann Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 Journal of Experimental Medicine 201 2005 647 657 (Pubitemid 40289554)
12. I.R. Turnbull, S. Gilfillan, M. Cella, T. Aoshi, M. Miller, and L. Piccio Cutting edge: TREM-2 attenuates macrophage activation Journal of Immunology 177 2006 3520 3524 (Pubitemid 44359882)
13. M.M. Suzuki, and A. Bird DNA methylation landscapes: provocative insights from epigenomics Nature Reviews Genetics 9 2008 465 476 (Pubitemid 351693975)
14. E. Okun, K.J. Griffioen, and M.P. Mattson Toll-like receptor signaling in neural plasticity and disease Trends in Neurosciences 34 2011 269 281
15. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, and H. Sanjo A Toll-like receptor recognizes bacterial DNA Nature 408 2000 740 745 (Pubitemid 32015992)
16. Q. Zhang, M. Raoof, Y. Chen, Y. Sumi, T. Sursal, and W. Junger Circulating mitochondrial DAMPs cause inflammatory responses to injury Nature 464 2010 41 42
17. N.W. Tsai, T.K. Lin, S.D. Chen, W.N. Chang, H.C. Wang, and T.M. Yang The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke Clinica Chimica Acta 412 2011 476 479
18. T. Oka, S. Hikoso, O. Yamaguchi, M. Taneike, T. Takeda, and T. Tamai Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure Nature 485 2012 251 255
19. L. Margulis, and M.J. Chapman Endosymbioses: cyclical and permanent in evolution Trends in Microbiology 6 1998 342 345 (Pubitemid 28473186)
20. M. Monk, M. Boubelik, and S. Lehnert Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development Development 99 1987 371 382 (Pubitemid 17048855)
21. V.L. Wilson, R.A. Smith, and S. Ma Cutler RG. Genomic 5-methyldeoxycytidine decreases with age Journal of Biological Chemistry 262 1987 9948 9951
22. S.C. Wang, B. Oelze, and A. Schumacher Age-specific epigenetic drift in late-onset Alzheimer's disease PLoS ONE 3 2008 e2698
23. D. Mastroeni, A. Grover, E. Delvaux, C. Whiteside, P.D. Coleman, and J. Rogers Epigenetic mechanisms in Alzheimer's disease Neurobiology of Aging 32 2011 1161 1180
24. S.W. Bihaqi, A. Schumacher, B. Maloney, D.K. Lahiri, and N.H. Zawia Do epigenetic pathways initiate late onset Alzheimer disease (LOAD): towards a new paradigm Current Alzheimer Research 9 2012 574 588
25. K.M. Bakulski, D.C. Dolinoy, M.A. Sartor, H.L. Paulson, J.R. Konen, and A.P. Lieberman Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex Journal of Alzheimer's Disease 29 2012 571 588
26. S. Iraola-Guzman, X. Estivill, and R. Rabionet DNA methylation in neurodegenerative disorders: a missing link between genome and environment Clinical Genetics 80 2011 1 14
27. G. Toperoff, D. Aran, J.D. Kark, M. Rosenberg, T. Dubnikov, and B. Nissan Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood Human Molecular Genetics 21 2012 371 383
28. J. Feng, Y. Zhou, S.L. Campbell, T. Le, E. Li, and J.D. Sweatt Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons Nature Neuroscience 13 2010 423 430
29. J.U. Guo, D.K. Ma, H. Mo, M.P. Ball, M.H. Jang, and M.A. Bonaguidi Neuronal activity modifies the DNA methylation landscape in the adult brain Nature Neuroscience 14 2011 1345 1351
30. E. Zuckerkandl Why so many noncoding nucleotides? The eukaryote genome as an epigenetic machine Genetica 115 2002 105 129 (Pubitemid 34842174)
31. J. Atamaniuk, C. Kopecky, S. Skoupy, M.D. Saemann, and T. Weichhart Apoptotic cell-free DNA promotes inflammation in haemodialysis patients Nephrology, Dialysis, Transplantation 27 2012 902 905
32. J.L. Park, H.J. Kim, B.Y. Choi, H.C. Lee, H.R. Jang, and K.S. Song Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients Oncology Letters 3 2012 921 926
33. D. Kaul, P. Habbel, K. Derkow, C. Kruger, E. Franzoni, and F.G. Wulczyn Expression of Toll-like receptors in the developing brain PLoS ONE 7 2012 e37767
34. N.B. Butchi, M. Du, and K.E. Peterson Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia Glia 58 2010 650 664
35. I.A. Clark, L.M. Alleva, and B. Vissel The roles of TNF in brain dysfunction and disease Pharmacology & Therapeutics 128 2010 519 548
36. G.M. Deng, Z.Q. Liu, and A. Tarkowski Intracisternally localized bacterial DNA containing CpG motifs induces meningitis Journal of Immunology 167 2001 4616 4626 (Pubitemid 32954342)
37. X. Zhao, T. Ueba, B.R. Christie, B. Barkho, M.J. McConnell, and K. Nakashima Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function Proceedings of the National Academy of Sciences of the United States of America 100 2003 6777 6782 (Pubitemid 36666656)
38. S.C. Tauber, S. Ebert, J.H. Weishaupt, A. Reich, R. Nau, and J. Gerber Stimulation of Toll-like receptor 9 by chronic intraventricular unmethylated cytosine-guanine DNA infusion causes neuroinflammation and impaired spatial memory Journal of Neuropathology and Experimental Neurology 68 2009 1116 1124
39. A.M. Oliveira, T.J. Hemstedt, and H. Bading Rescue of aging-associated decline in Dnmt3a2 expression restores cognitive abilities Nature Neuroscience 15 2012 1111 1113
40. G. Zhang, J. Li, S. Purkayastha, Y. Tang, H. Zhang, and Y. Yin Hypothalamic programming of systemic ageing involving IKK-beta, NF-kappaB and GnRH Nature 497 2013 211 216
41. L. Maroteaux, J.T. Campanelli, and R.H. Scheller Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal Journal of Neuroscience 8 1988 2804 2815
42. E.C. Shin, S.E. Cho, D.K. Lee, M.W. Hur, S.R. Paik, and J.H. Park Expression patterns of alpha-synuclein in human hematopoietic cells and in Drosophila at different developmental stages Molecules and Cells 10 2000 65 70
43. A.J. Brookes, and D. St Clair Synuclein proteins and Alzheimer's disease Trends in Neurosciences 17 1994 404 405 (Pubitemid 24288204)
44. M. Goedert Familial Parkinson's disease. The awakening of alpha-synuclein Nature 388 1997 232 233
45. M.E. Larson, M.A. Sherman, S. Greimel, M. Kuskowski, J.A. Schneider, and D.A. Bennett Soluble alpha-synuclein is a novel modulator of Alzheimer's disease pathophysiology Journal of Neuroscience 32 2012 10253 10266
46. P. Desplats, B. Spencer, E. Coffee, P. Patel, S. Michael, and C. Patrick Alpha-synuclein sequesters DNMT1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases Journal of Biological Chemistry 286 2011 9031 9037
47. D. Mastroeni, A. Grover, E. Delvaux, C. Whiteside, P.D. Coleman, and J. Rogers Epigenetic changes in Alzheimer's disease: decrements in DNA methylation Neurobiology of Aging 31 2010 2025 2037
48. C.S. Wang, J.R. Burke, D.C. Steffens, C.M. Hulette, J.C. Breitner, and B.L. Plassman Twin pairs discordant for neuropathologically confirmed Lewy body dementia Journal of Neurology, Neurosurgery and Psychiatry 80 2009 562 565
49. L. Alvarez-Erviti, Y. Couch, J. Richardson, J.M. Cooper, and M.J. Wood Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line Neuroscience Research 69 2011 337 342
50. D. Kirik, C. Rosenblad, C. Burger, C. Lundberg, T.E. Johansen, and N. Muzyczka Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system Journal of Neuroscience 22 2002 2780 2791 (Pubitemid 37465827)
51. A. Eslamboli, M. Romero-Ramos, C. Burger, T. Bjorklund, N. Muzyczka, and R.J. Mandel Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain Brain 130 2007 799 815 (Pubitemid 46410741)
52. H. Hayashita-Kinoh, M. Yamada, T. Yokota, Y. Mizuno, and H. Mochizuki Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model Biochemical and Biophysical Research Communications 341 2006 1088 1095 (Pubitemid 43221777)
53. J. Wu, M.R. Basha, B. Brock, D.P. Cox, F. Cardozo-Pelaez, and C.A. McPherson Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD Journal of Neuroscience 28 2008 3 9
54. S.W. Bihaqi, H. Huang, J. Wu, and N.H. Zawia Infant exposure to lead (Pb) and epigenetic modifications in the aging primate brain: implications for Alzheimer's disease Journal of Alzheimer's Disease 27 2011 819 833
55. J. Zhang, T. Cai, F. Zhao, T. Yao, Y. Chen, and X. Liu The role of alpha-synuclein and tau hyperphosphorylation-mediated autophagy and apoptosis in lead-induced learning and memory injury International Journal of Biological Sciences 8 2012 935 944
56. R.J. Donnelly, A.J. Friedhoff, B. Beer, A.J. Blume, and M.P. Vitek Interleukin-1 stimulates the beta-amyloid precursor protein promoter Cellular and Molecular Neurobiology 10 1990 485 495
57. T.L. Guo, S.P. Mudzinski, and D.A. Lawrence The heavy metal lead modulates the expression of both TNF-alpha and TNF-alpha receptors in lipopolysaccharide-activated human peripheral blood mononuclear cells Journal of Leukocyte Biology 59 1996 932 939 (Pubitemid 26238491)
58. Y.J. Cheng, B.C. Yang, and M.Y. Liu Lead increases lipopolysaccharide- induced liver-injury through tumor necrosis factor-alpha overexpression by monocytes/macrophages: role of protein kinase C and P42/44 mitogen-activated protein kinase Environmental Health Perspectives 114 2006 507 513
59. K. Das, M. Ghosh, C. Nag, S.P. Nandy, M. Banerjee, and M. Datta Role of familial, environmental and occupational factors in the development of Parkinson's disease Neurodegenerative Diseases 8 2011 345 351
60. H. Jang, D. Boltz, K. Sturm-Ramirez, K.R. Shepherd, Y. Jiao, and R. Webster Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration Proceedings of the National Academy of Sciences of the United States of America 106 2009 14063 14068
61. C.Y. Cheung, L.L.M. Poon, A.S. Lau, W. Luk, Y.L. Lau, and K.F. Shortridge Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease Lancet 360 2002 1831 1837 (Pubitemid 35449422)
62. R.J. Castellani, G. Perry, and M.A. Smith Prion disease and Alzheimer's disease: pathogenic overlap Acta Neurobiologiae Experimentalis (Wars) 64 2004 11 17 (Pubitemid 38453802)
63. K.T. Adjou, S. Allix, M.O. Ouidja, S. Backer, C. Couquet, and M.J. Cornuejols Alpha-synuclein accumulates in the brain of scrapie-affected sheep and goats Journal of Comparative Pathology 137 2007 78 81 (Pubitemid 47044753)
64. H. Jang, D.A. Boltz, R.G. Webster, and R.J. Smeyne Viral parkinsonism Biochimica et Biophysica Acta 1792 2009 714 721
65. T. Kawasaki, T. Kawai, and S. Akira Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity Immunological Reviews 243 2011 61 73
66. J.D. Sipe, S.N. Vogel, J.L. Ryan, K.P. McAdam, and D.L. Rosenstreich Detection of a mediator derived from endotoxin-stimulated macrophages that induces the acute phase serum amyloid A response in mice Journal of Experimental Medicine 150 1979 597 606 (Pubitemid 10232138)
67. G. Marhaug, and S.B. Dowton Serum amyloid A: an acute phase apolipoprotein and precursor of AA amyloid Baillieres Clinical Rheumatology 8 1994 553 573 (Pubitemid 24256891)
68. D.J. Selkoe, M.B. Podlisny, C.L. Joachim, E.A. Vickers, G. Lee, and L.C. Fritz Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues Proceedings of the National Academy of Sciences of the United States of America 85 1988 7341 7345
69. M. Pickering, D. Cumiskey, and J.J. O'Connor Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system Experimental Physiology 90 2005 663 670 (Pubitemid 41406053)
70. E.C. Beattie, D. Stellwagen, W. Morishita, J.C. Bresnahan, B.K. Ha, and M. Von Zastrow Control of synaptic strength by glial TNFalpha Science 295 2002 2282 2285 (Pubitemid 34258846)
71. D. Stellwagen, E.C. Beattie, J.Y. Seo, and R.C. Malenka Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha Journal of Neuroscience 25 2005 3219 3228 (Pubitemid 40463557)
72. X. Han, M. Chen, F. Wang, M. Windrem, S. Wang, and S. Shanz Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice Cell Stem Cell 12 2013 342 353
73. D. Tweedie, K. Sambamurti, and N.H. Greig TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets Current Alzheimer Research 4 2007 378 385 (Pubitemid 47421968)
74. J. Zhao, T. O'Connor, and R. Vassar The contribution of activated astrocytes to Abeta production: implications for Alzheimer's disease pathogenesis Journal of Neuroinflammation 8 2011 150
75. T. Korn, E. Bettelli, M. Oukka, and V.K. Kuchroo IL-17 and Th17 cells Annual Review of Immunology 27 2009 485 517
76. A. Mori, E. Oleszycka, F.A. Sharp, M. Coleman, Y. Ozasa, and M. Singh The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses European Journal of Immunology 42 2012 2709 2719
77. J.M. Benson, C.W. Sachs, G. Treacy, H. Zhou, C.E. Pendley, and C.M. Brodmerkel Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab Nature Biotechnology 29 2011 615 624
78. C.L. Langrish, Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, and J.D. Sedgwick IL-23 drives a pathogenic T cell population that induces autoimmune inflammation Journal of Experimental Medicine 201 2005 233 240 (Pubitemid 40189432)
79. W.E. Paul, and J. Ohara B-cell stimulatory factor-1/interleukin 4 Annual Review of Immunology 5 1987 429 459
80. R.K. Puri, and P. Leland Tumor necrosis factor upregulates interleukin-4 receptors on murine sarcoma cells Biochemical and Biophysical Research Communications 197 1993 1424 1430 (Pubitemid 24042781)
81. P.H. Hart, R.L. Cooper, and J.J. Finlay-Jones IL-4 suppresses IL-1 beta, TNF-alpha and PGE2 production by human peritoneal macrophages Immunology 72 1991 344 349
82. S. Sarkar, L.A. Cooney, P. White, D.B. Dunlop, J. Endres, and J.M. Jorns Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4 Arthritis Research and Therapy 11 2009 R158
83. J. Kipnis, H. Cohen, M. Cardon, Y. Ziv, and M. Schwartz T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions Proceedings of the National Academy of Sciences of the United States of America 101 2004 8180 8185 (Pubitemid 38698074)
84. A. Brynskikh, T. Warren, J. Zhu, and J. Kipnis Adaptive immunity affects learning behavior in mice Brain, Behavior, and Immunity 22 2008 861 869
85. Y. Nolan, F.O. Maher, D.S. Martin, R.M. Clarke, M.T. Brady, and A.E. Bolton Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus Journal of Biological Chemistry 280 2005 9354 9362 (Pubitemid 40409629)
86. T. Kiyota, S. Okuyama, R.J. Swan, M.T. Jacobsen, H.E. Gendelman, and T.C.N.S. Ikezu expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP + PS1 bigenic mice FASEB Journal 24 2010 3093 3102
87. N.C. Derecki, A.N. Cardani, C.H. Yang, K.M. Quinnies, A. Crihfield, and K.R. Lynch Regulation of learning and memory by meningeal immunity: a key role for IL-4 Journal of Experimental Medicine 207 2010 1067 1080
88. J.J. O'Connor Targeting tumour necrosis factor-alpha in hypoxia and synaptic signalling Irish Journal of Medical Science 82 2013 157 162
89. X. Xiong, G.E. Barreto, L. Xu, Y.B. Ouyang, X. Xie, and R.G. Giffard Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia Stroke 42 2011 2026 2032
90. J. Kipnis, S. Gadani, and N.C. Derecki Pro-cognitive properties of T cells Nature Reviews Immunology 12 2012 663 669
91. P. Kivisakk, D.J. Mahad, M.K. Callahan, C. Trebst, B. Tucky, and T. Wei Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin Proceedings of the National Academy of Sciences of the United States of America 100 2003 8389 8394 (Pubitemid 36842555)
92. A. Cayota, F. Vuillier, D. Scott-Algara, V. Feuillie, and G. Dighiero Impaired proliferative capacity and abnormal cytokine profile of naive and memory CD4T cells from HIV-seropositive patients Clinical and Experimental Immunology 88 1992 478 483
93. M.J. Moravan, J.A. Olschowka, J.P. Williams, and M.K. O'Banion Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain Radiation Research 176 2011 459 473
94. J. Kipnis, N.C. Derecki, C. Yang, and H. Scrable Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common Trends in Immunology 29 2008 455 463
95. P.P. Amaral, M.E. Dinger, and J.S. Mattick Non-coding RNAs in homeostasis, disease and stress responses: an evolutionary perspective Briefings in Functional Genomics 12 2013 254 278
96. P. Shapshak Molecule of the month: miRNA and proteins in Alzheimer's disease Bioinformation 9 2013 222 223
97. W.J. Lukiw, P.N. Alexandrov, Y. Zhao, J.M. Hill, and S. Bhattacharjee Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA NeuroReport 23 2012 621 626
98. B.I. Laufer, K. Mantha, M.L. Kleiber, E.J. Diehl, S.M. Addison, and S.M. Singh Long-lasting alterations to DNA methylation and ncRNAs could underlie the effects of fetal alcohol exposure in mice Disease Models & Mechanisms 6 2013 977 992
99. X. Mao, S. Sarkar, and S.L. Chang Involvement of the NLRP3 inflammasome in the modulation of an LPS-induced inflammatory response during morphine tolerance Drug and Alcohol Dependence 2013 in press
100. D. McGonagle, S. Savic, and M.F. McDermott The NLR network and the immunological disease continuum of adaptive and innate immune-mediated inflammation against self Seminars in Immunopathology 29 2007 303 313 (Pubitemid 47416222)
101. M.T. Heneka, M.P. Kummer, A. Stutz, A. Delekate, S. Schwartz, and A. Vieira-Saecker NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice Nature 493 2013 674 678
102. L. Franchi, T. Eigenbrod, and G. Nunez Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation Journal of Immunology 183 2009 792 796
103. M. Barbieri, M. Bonafe, C. Franceschi, and G. Paolisso Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans American Journal of Physiology. Endocrinology and metabolism 285 2003 E1064 E1071
104. S. Craft, S. Asthana, J.W. Newcomer, C.W. Wilkinson, I.T. Matos, and L.D. Baker Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose Archives of General Psychiatry 56 1999 1135 1140
105. S. Hoyer, D. Muller, and K. Plaschke Desensitization of brain insulin receptor. Effect on glucose/energy and related metabolism Journal of Neural Transmission Supplementum 44 1994 259 268 (Pubitemid 24372903)
106. A. Chawla, K.D. Nguyen, and Y.P. Goh Macrophage-mediated inflammation in metabolic disease Nature Reviews Immunology 11 2011 738 749
107. J. Zhao, J. Goldberg, J.D. Bremner, and V. Vaccarino Global DNA methylation is associated with insulin resistance: a monozygotic twin study Diabetes 61 2012 542 546
108. J.J. Holst, R. Burcelin, and E. Nathanson Neuroprotective properties of GLP-1: theoretical and practical applications Current Medical Research and Opinion 27 2011 547 558
109. R. Stienstra, L.A. Joosten, T. Koenen, B. van Tits, J.A. van Diepen, and S.A. van den Berg The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity Cell Metabolism 12 2010 593 605
110. P.L. McClean, V. Parthsarathy, E. Faivre, and C. Holscher The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease Journal of Neuroscience 31 2011 6587 6594
111. L.A. Zuniga, W.J. Shen, B. Joyce-Shaikh, E.A. Pyatnova, A.G. Richards, and C. Thom IL-17 regulates adipogenesis, glucose homeostasis, and obesity Journal of Immunology 185 2010 6947 6959
112. Y.H. Chang, K.T. Ho, S.H. Lu, C.N. Huang, and M.Y. Shiau Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4 International Journal of Obesity (London) 36 2012 993 998
113. L.A. Ozbay, N. Moller, C. Juhl, M. Bjerre, J. Carstens, and J. Rungby Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers British Journal of Clinical Pharmacology 73 2012 536 545
114. G.R. Crabtree, and E.N. Olson NFAT signaling: choreographing the social lives of cells Cell 109 Suppl. 2002 S67 S79
115. G.R. Crabtree, and S.L. Schreiber SnapShot. Ca2 + -calcineurin-NFAT signalling Cell 138 2009 pp. 210, e1
116. A. Canellada, E. Cano, L. Sanchez Ruiloba, F. Zafra, and J.M. Redondo Calcium-dependent expression of TNF-alpha in neural cells is mediated by the calcineurin/NFAT pathway Molecular and Cellular Neurosciences 31 2006 692 701
117. C.P. Gilman, T. Perry, K. Furukawa, N.H. Grieg, J.M. Egan, and M.P. Mattson Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons Journal of Neurochemistry 87 2003 1137 1144 (Pubitemid 37485070)
118. T.H. Chen, H.T. Wo, C.C. Wu, J.L. Wang, C.C. Wang, and I.C. Hsieh Exendin-4 attenuates lipopolysaccharides induced inflammatory response but does not protect H9c2 cells from apoptosis Immunopharmacology and Immunotoxicology 34 2012 484 490
119. S.L. Schreiber, and G.R. Crabtree The mechanism of action of cyclosporin A and FK506 Immunology Today 13 1992 136 142
120. A.E. Goldfeld, E. Tsai, R. Kincaid, P.J. Belshaw, S.L. Schrieber, and J.L. Strominger Calcineurin mediates human tumor necrosis factor alpha gene induction in stimulated T and B cells Journal of Experimental Medicine 180 1994 763 768 (Pubitemid 24224159)
121. K.T. Dineley, D. Hogan, W.R. Zhang, and G. Taglialatela Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice Neurobiology of Learning and Memory 88 2007 217 224 (Pubitemid 47223751)
122. N.G. Faux, C.W. Ritchie, A. Gunn, A. Rembach, A. Tsatsanis, and J. Bedo PBT2 rapidly improves cognition in Alzheimer's disease: additional phase II analyses Journal of Alzheimer's Disease 20 2010 509 516
123. P.A. Adlard, R.A. Cherny, D.I. Finkelstein, E. Gautier, E. Robb, and M. Cortes Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta Neuron 59 2008 43 55 (Pubitemid 351905863)
124. P.J. Crouch, M.S. Savva, L.W. Hung, P.S. Donnelly, A.I. Mot, and S.J. Parker The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity Journal of Neurochemistry 119 2011 220 230
125. R.W. Mahley Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
126. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, and G.W. Small Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923 (Pubitemid 23275809)
127. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak Vance, J. Enghild, and G.S. Salvesen Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 90 1993 1977 1981 (Pubitemid 23069980)
128. N. de Bont, M.G. Netea, P.N. Demacker, I. Verschueren, B.J. Kullberg, and K.W. van Dijk Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection Journal of Lipid Research 40 1999 680 685 (Pubitemid 29173771)
129. E.H. Corder, K. Robertson, L. Lannfelt, N. Bogdanovic, G. Eggertsen, and J. Wilkins HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy Nature Medicine 4 1998 1182 1184 (Pubitemid 28468833)
130. C. Aucan, A.J. Walley, and A.V.S. Hill Common apolipoprotein E polymorphisms and risk of clinical malaria in the Gambia Journal of Medical Genetics 41 2004 21 24 (Pubitemid 38125683)
131. G.A. Dore, M.F. Elias, M.A. Robbins, P.K. Elias, and Z. Nagy Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse study Diabetologia 52 2009 2551 2560
132. R.W. Mahley, K.H. Weisgraber, and Y. Huang Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 103 2006 5644 5651
133. N. Mariappan, C.M. Elks, B. Fink, and J. Francis TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction Free Radical Biology and Medicine 46 2009 462 470
134. D.T. Laskowitz, S. Goel, E.R. Bennett, and W.D. Matthew Apolipoprotein E suppresses glial cell secretion of TNF-alpha Journal of Neuroimmunology 76 1997 70 74 (Pubitemid 27272630)
135. J.R. Lynch, D. Morgan, J. Mance, W.D. Matthew, and D.T. Laskowitz Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response Journal of Neuroimmunology 114 2001 107 113 (Pubitemid 32184731)
136. K. Ali, M. Middleton, E. Pure, and D.J. Rader Apolipoprotein E suppresses the type I inflammatory response in vivo Circulation Research 97 2005 922 927 (Pubitemid 41552678)
137. M.P. Vitek, C.M. Brown, and C.A. Colton APOE genotype-specific differences in the innate immune response Neurobiology of Aging 30 2009 1350 1360
138. V.B. Gupta, S.M. Laws, V.L. Villemagne, D. Ames, A.I. Bush, and K.A. Ellis Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging Neurology 76 2011 1091 1098
139. D.T. Laskowitz, A.D. Thekdi, S.D. Thekdi, S.K. Han, J.K. Myers, and S.V. Pizzo Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides Experimental Neurology 167 2001 74 85 (Pubitemid 32093924)
140. J.R. Lynch, H. Wang, B. Mace, S. Leinenweber, D.S. Warner, and E.R. Bennett A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury Experimental Neurology 192 2005 109 116 (Pubitemid 40208543)
141. E.A. Tukhovskaya, A.Y. Yukin, O.N. Khokhlova, A.N. Murashev, and M.P. Vitek COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia Journal of Neuroscience Research 87 2009 677 682
142. M.P. Vitek, D.J. Christensen, D. Wilcock, J. Davis, W.E. Van Nostrand, and F.Q. Li APOE-mimetic peptides reduce behavioral deficits, plaques and tangles in Alzheimer's disease transgenics Neurodegenerative Diseases 31 2012 359 369
143. P.E. Cramer, J.R. Cirrito, D.W. Wesson, C.Y. Lee, J.C. Karlo, and A.E. Zinn ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models Science 335 2012 1503 1506
144. A.R. Price, G. Xu, Z.B. Siemienski, L.A. Smithson, D.R. Borchelt, and T.E. Golde Comment on ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models Science 340 2013 924 930
145. D. Goldgaber, H.W. Harris, T. Hla, T. Maciag, R.J. Donnelly, and J.S. Jacobsen Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells Proceedings of the National Academy of Sciences of the United States of America 86 1989 7606 76010
146. J. Schmidt, K. Barthel, A. Wrede, M. Salajegheh, M. Bahr, and M.C. Dalakas Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle Brain 131 2008 1228 1240
147. G. Sommer, S. Kralisch, J. Lipfert, S. Weise, K. Krause, and B. Jessnitzer Amyloid precursor protein expression is induced by tumor necrosis factor alpha in 3T3-L1 adipocytes Journal of Cellular Biochemistry 108 2009 1418 1422
148. B. Brugg, Y.L. Dubreuil, G. Huber, E.E. Wollman, N. Delhaye Bouchaud, and J. Mariani Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain Proceedings of the National Academy of Sciences of the United States of America 92 1995 3032 3035
149. Y.W. Ge, and D.K. Lahiri Regulation of promoter activity of the APP gene by cytokines and growth factors: implications in Alzheimer's disease Annals of the New York Academy of Sciences 973 2002 463 467 (Pubitemid 36125054)
150. Y.F. Liao, B.J. Wang, H.T. Cheng, L.H. Kuo, and M.S. Wolfe Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a
151. T. Alkam, A. Nitta, H. Mizoguchi, K. Saito, M. Seshima, and A. Itoh Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice Behavioural Brain Research 189 2008 100 106
152. A. Halle, V. Hornung, G.C. Petzold, C.R. Stewart, B.G. Monks, and T. Reinheckel The NALP3 inflammasome is involved in the innate immune response to amyloid-beta Nature Immunology 9 2008 857 865
153. C. Holmes, D. Boche, D. Wilkinson, G. Yadegarfar, V. Hopkins, and A. Bayer Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial Lancet 372 2008 216 223 (Pubitemid 351978111)
154. F.T. Crews, J. Zou, and L. Qin Induction of innate immune genes in brain create the neurobiology of addiction Brain, Behavior, and Immunity 25 Suppl. 1 2011 S4 S12
155. R.H. Shirazi, S.L. Dickson, and K.P. Skibicka Gut peptide GLP-1 and its analogue, exendin-4, decrease alcohol intake and reward PLoS ONE 8 2013 e61965
156. M. Kiaei, S. Petri, K. Kipiani, G. Gardian, D.K. Choi, and J. Chen Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis Journal of Neuroscience 26 2006 2467 2473 (Pubitemid 44699007)
157. A.S. Harms, C.J. Barnum, K.A. Ruhn, S. Varghese, I. Trevino, and A. Blesch Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease Molecular Therapy 19 2011 46 52
158. C.M. Wilson, M.W. Gaber, O.M. Sabek, J.A. Zawaski, and T.E. Merchant Radiation-induced astrogliosis and blood-brain barrier damage can be abrogated using anti-TNF treatment International Journal of Radiation Oncology, Biology, Physics 74 2009 934 941
159. R.O. Williams, M. Feldmann, and R.N. Maini Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis Proceedings of the National Academy of Sciences of the United States of America 89 1992 9784 9788
160. C.C. Chio, J.W. Lin, M.W. Chang, C.C. Wang, C.Z. Yang, and C.P. Chang Therapeutic evaluation of etanercept in a model of traumatic brain injury Journal of Neurochemistry 115 2010 921 929
161. E.L. Tobinick, H. Gross, A. Weinberger, and H. Cohen TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study MedGenMed Neurology & Neurosurgery 8 2006 25
162. H.M. van Dullemen, S.J. van Deventer, D.W. Hommes, H.A. Bijl, J. Jansen, and G.N. Tytgat Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2) Gastroenterology 109 1995 129 135
163. M.J. Elliott, R.N. Maini, M. Feldmann, J.R. Kalden, C. Antoni, and J.S. Smolen Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1105 1110 (Pubitemid 24317629)
164. E. Tobinick, N.M. Kim, G. Reyzin, H. Rodriguez-Romanacce, and V. DePuy Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept CNS Drugs 26 2012 1051 1070
165. J. Vom Berg, S. Prokop, K.R. Miller, J. Obst, R.E. Kalin, and I. Lopategui-Cabezas Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline Nature Medicine 2012
166. Q. Guan, Y. Ma, C.L. Hillman, A. Ma, G. Zhou, and G. Qing Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis Vaccine 27 2009 7096 7104
167. A.W. Clarke, L. Poulton, H.Y. Wai, S.A. Walker, S.D. Victor, and T. Domagala A novel class of anti-IL-12p40 antibodies: potent neutralization via inhibition of IL-12-IL-12Rbeta2 and IL-23-IL-23R MAbs 2 2010 539 549
168. F. Konoeda, T. Shichita, H. Yoshida, Y. Sugiyama, G. Muto, and E. Hasegawa Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model Biochemical and Biophysical Research Communications 402 2010 500 506
169. W.J. Sandborn, C. Gasink, L.L. Gao, M.A. Blank, J. Johanns, and C. Guzzo Ustekinumab induction and maintenance therapy in refractory Crohn's disease New England Journal of Medicine 367 2012 1519 1528
170. C.L. Leonardi, A.B. Kimball, K.A. Papp, N. Yeilding, C. Guzzo, and Y. Wang Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) Lancet 371 2008 1665 1674 (Pubitemid 351671883)
171. E. Egecioglu, P. Steensland, I. Fredriksson, K. Feltmann, J.A. Engel, and E. Jerlhag The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents Psychoneuroendocrinology 38 2012 1259 1270
172. Y. Li, S. Chigurupati, H.W. Holloway, M. Mughal, D. Tweedie, and D.A. Bruestle Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis PLoS ONE 7 2012 e32008
173. Y. Li, T. Perry, M.S. Kindy, B.K. Harvey, D. Tweedie, and H.W. Holloway GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism Proceedings of the National Academy of Sciences of the United States of America 106 2009 1285 1290
174. V. Parthsarathy, and C. Holscher The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain European Journal of Pharmacology 700 2012 42 50
175. V. Darsalia, S. Mansouri, H. Ortsater, A. Olverling, N. Nozadze, and C. Kappe Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in type 2 diabetic rats Clinical Science (London) 122 2012 473 483
176. L. Rachmany, D. Tweedie, Y. Li, V. Rubovitch, H.W. Holloway, and J. Miller Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice Age (Dordr) 2013 in press
177. D. Tweedie, L. Rachmany, V. Rubovitch, E. Lehrmann, Y. Zhang, and K.G. Becker Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice Experimental Neurology 239 2013 170 182
178. I. Aviles-Olmos, J. Dickson, Z. Kefalopoulou, A. Djamshidian, P. Ell, and T. Soderlund Exenatide and the treatment of patients with Parkinson's disease Journal of Clinical Investigation 123 2013 2730 2736
179. T. Ahern, A.M. Tobin, M. Corrigan, A. Hogan, C. Sweeney, and B. Kirby Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study Journal of the European Academy of Dermatology and Venereology 2013 in press
180. W.M. Pardridge Biologic TNFalpha-inhibitors that cross the human blood-brain barrier Bioengineered Bugs 1 2010 231 234
181. N.H. Greig, T. Giordano, X. Zhu, Q.S. Yu, T.A. Perry, and H.W. Holloway Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases Acta Neurobiologiae Experimentalis 64 2004 1 9 (Pubitemid 38453801)
182. C. Pottier, D. Wallon, S. Rousseau, A. Rovelet-Lecrux, A.C. Richard, and A. Rollin-Sillaire TREM2 R47H Variant as a risk factor for early-onset Alzheimer's disease Journal of Alzheimer's Disease 35 2013 45 49